Related Articles
Analysis of the role of DAMTC in lung adenocarcinoma cells based on the DNA microarrays
Revealing hub pathway cross-talk for premature newborns with bronchopulmonary dysplasia by the integration of pathway analysis and Monte Carlo Cross-Validation
Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway
YRDC is upregulated in non‑small cell lung cancer and promotes cell proliferation by decreasing cell apoptosis
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer